Cite
HARVARD Citation
Lopez‐Lopez, C. et al. (n.d.). [O2–17–05]: RATIONALE FOR CNP520 DOSE SELECTION FOR THE PIVOTAL CLINICAL PROGRAM IN PRECLINICAL AD. Alzheimer's & dementia. pp. P601-P602. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lopez‐Lopez, C. et al. (n.d.). [O2–17–05]: RATIONALE FOR CNP520 DOSE SELECTION FOR THE PIVOTAL CLINICAL PROGRAM IN PRECLINICAL AD. Alzheimer's & dementia. pp. P601-P602. [Online].